论文部分内容阅读
[目的] 探讨健康体检人群房颤发病的相关影响因素.[方法] 回顾性分析2013年6月至2016年6月来本院进行健康检查的11375例研究对象的临床资料,根据是否发生心房颤动将其分为心房颤动组(n=52)和非心房颤动组(n=11323).比较两组研究对象的临床资料,分析健康体检人群房颤发病的相关影响因素.[结果] 11375例健康体检者共计52例心房颤动患者,其中31例(59.61%)为阵发性心房颤动、16例(30.76%)为持续性心房颤动、5例(9.63%)为永久性心房颤动.心房颤动组年龄、心率均显著大于非心房颤动组,服用降压药物、糖尿病史所占比例显著高于非心房颤动组,心房颤动组体质量指数(BMI)、舒张压(DBP)、收缩压(SBP)与非心房颤动组比较,差异均具有统计学意义(均P<0.05).高心率、高BMI、高DBP、高SBP、卒中史为健康体检人群房颤发病的危险因素(均P<0.05).[结论] 高心率、高BMI、高DBP、高SBP、卒中史为健康体检人群房颤发病的危险因素,应加强对这类患者的监控,做到早发现、早治疗.“,”[Objective]To investigate the factors related to the incidence of atrial fibrillation in healthy population.[Methods]Clinical data of 11,375 patients who were examined in our hospital from June 2013 to June 2016 were retrospectively analyzed.The patients were divided into atrial fibrillation group (n=52) and non atrial fibrillation group (n=11,323) according to the occurrence of atrial fibrillation.The clinical data of the two groups were compared and analyzed.[Results]A total of 52 patients with atrial fibrillation were enrolled in a total of 11375 healthy subjects,Among them, 31 cases (59.61%) were paroxysmal atrial fibrillation (AF), and persistent atrial fibrillation (AF) was found in 16 patients (30.76%), and permanent atrial fibrillation (AF) was found in 5 patients (9.63%);The age and heart rate of atrial fibrillation group were significantly higher than those of non atrial fibrillation group.The incidence of diabetes mellitus and taking antihypertensive drugs were significantly higher than those of the non atrial fibrillation group;The body mass index (BMI), diastolic pressure (DBP), systolic pressure (SBP) of the atrial fibrillation (AF) group were statistically significant compared with.Those of the non-atrial fibrillation (AF) group (mean P<0.05).High heart rate, high BMI, high DBP, high SBP and stroke history were risk factors for atrial fibrillation in healthy population(mean P<0.05).[Conclusion]High heart rate, high BMI, high DBP, high SBP, and stroke history are risk factors for atrial fibrillation in healthy population.Attention should be payed to strengthen the monitoring of such patients for early detection and early treatment.